![1]()
News
Case reports illustrate heterogeneity of skin manifestations in COVID patients
May 5, 2020
Any health professional is invited to submit cases of COVID-19–associated dermatoses to a registry set up by the American Academy of Dermatology.
![1]()
News
FDA tightens requirements for COVID-19 antibody tests
May 4, 2020
The U.S. Food and Drug Administration is tightening requirements for companies that develop COVID-19 antibody tests in an effort to combat fraud and better regulate the frenzy of tests coming to market.[[{"fid":"174399","view_mode":"medstat_image_flush_right","fields":{"...
![1]()
News
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
May 4, 2020
Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients treated with hydroxychloroquine.
![1]()
Opinion
COVID-19: To have and to hold … in quarantine
May 4, 2020
All of us can benefit from these skills, especially emotionally volatile couples who are trapped together in quarantine, Dr. Dara Abraham said.
![1]()
News
FDA authorizes emergency use of remdesivir for COVID-19
May 2, 2020
The designation means remdesivir can be distributed in the United States and administered intravenously by healthcare providers, as appropriate, to treat severe disease.
News
CMS hikes telephone visit payments during pandemic
May 1, 2020
Physician groups praised the move to increase payments for telephone visits.
![1]()
News
Primary care physicians reshuffle their work, lives in a pandemic
May 1, 2020
“Our knowledge of this disease is five steps behind, and changing at lightning speed,” said Dr. MaryAnn Dakkak.
News
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
May 1, 2020
Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%.
News
COVID-19: A ‘marathon, not a sprint’ for psychiatry
May 1, 2020
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
News
New study of diabetes drug for COVID-19 raises eyebrows
May 1, 2020
Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce adverse outcomes of COVID-19.
